Related Articles
Antisense oligodeoxynucleotide against human telomerase reverse transcriptase inhibits the proliferation of Eca‑109 esophageal carcinoma cells
Human telomerase reverse transcriptase antisense treatment downregulates the viability of prostate cancer cells in vitro
Long-term suppression of telomerase expression in HeLa cell clones, transfected with an expression vector carrying siRNA targeting hTERT mRNA
Antisense oligonucleotides targeting human telomerase mRNA increases the radiosensitivity of nasopharyngeal carcinoma cells
Expression of human telomerase reverse transcriptase mediates the senescence of mesenchymal stem cells through the PI3K/AKT signaling pathway